Zoll Medical Appoints New CEO as Company Expands into Sleep Technologies
Zoll Medical Corporation's new CEO, Eric Knudsen, aims to drive growth in sleep-assistance technologies and oversee the launch of the Zenix monitor/defibrillator system. With a revenue increase to $2.4 billion projected for 2024, the company is well-positioned for continued expansion under Knudsen's leadership.
Theia Market Signal Identification - AI Assisted
Eric Knudsen has been appointed as the CEO of Zoll Medical Corporation, succeeding Jon Rennert, who has transitioned to chairman. Knudsen has been with the company for 13 years, and Zoll's revenue has nearly quintupled during this time, reaching $2.4 billion in 2024.
Key objectives for Knudsen include the rollout of the Zenix monitor/defibrillator and expanding into sleep-assistance technologies, building on the Itamar acquisition. In related regional developments, Massachusetts Governor Maura Healey emphasized the need for data centers to support the innovation economy, while Boston Mayor Michelle Wu is actively seeking a new chief of economic opportunity. The region's business leaders are engaged in discussions about improving Boston's competitiveness in attracting talent and innovation.
Comments